How many insider trades does FilingIQ track for PLSE?

FilingIQ tracks 247 Form 4 insider transactions for PLSE (PULSE BIOSCIENCES, INC.), covering filings from Nov 16, 2016 onwards. 10 of those were filed in the last 90 days.

Are PLSE insiders net buyers or net sellers?

Across the full Form 4 history for PLSE, 104 transactions (42%) were open-market purchases and 18 (7%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does PLSE insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is PLSE in?

PULSE BIOSCIENCES, INC. (PLSE) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $1.32B.

PLSE insider trading

NasdaqCM Healthcare

PULSE BIOSCIENCES, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

247

Last 90 days

Buys / sells

42% / 7%

Market cap

$1.32B

About PULSE BIOSCIENCES, INC.

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; CellFX nsPFA Percutaneous Electrode system for soft tissue ablation in surgical setting; CellFX nsPFA Cardiac Clamp designed for use in surgical treatment of atrial fibrillation (AF); CellFX nsPFA 360° Cardiac Catheter designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.

Company website: www.pulsebiosciences.com

PLSE insider activity at a glance

FilingIQ has scored 247 insider transactions for PLSE since Nov 16, 2016. The most recent filing in our index is dated May 11, 2026.

Across the full history, 104 open-market purchases and 18 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PLSE insider trades is 51.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live PLSE trades on FilingIQ Raw filings on SEC EDGAR

Latest PLSE Form 4 filings

LAVIOLETTE PAUL A Chief Executive Officer

P May 11, 2026

UECKER DARRIN Chief Technology Officer

S Jun 13, 2025

Barrett Burke Thomas President and CEO

P May 20, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading PLSE

LAVIOLETTE PAUL A

2 trades · score 70.0

Frequently asked

How many insider trades does FilingIQ track for PLSE?: FilingIQ tracks 247 Form 4 insider transactions for PLSE (PULSE BIOSCIENCES, INC.), covering filings from Nov 16, 2016 onwards. 10 of those were filed in the last 90 days.
Are PLSE insiders net buyers or net sellers?: Across the full Form 4 history for PLSE, 104 transactions (42%) were open-market purchases and 18 (7%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PLSE insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is PLSE in?: PULSE BIOSCIENCES, INC. (PLSE) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $1.32B.

Methodology & sources

Every PLSE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.